Accenture (NYSE: ACN) has been ranked as the number one life science information technology (IT) services vendor in a global survey conducted by IDC Health Insights. It is the third consecutive year Accenture has received this ranking.
The ranking was cited in the report: “Perspective: IDC Health Insights' Top Preferred Life Science Technology Vendors for 2013,” which documents results from IDC Health Insights’ Leading Indicators in Life Science IT Spending Survey.” 1 The IDC Health Insights survey shows the majority of respondents expect to contract with Accenture during the next 12 months for IT services. Click here for a link to the report.
Anne O’Riordan, global managing director of Accenture’s Life Sciences practice, said, “We are pleased to be recognized again as the top IT provider for the life sciences industry, as measured by IDC Health Insights. I am proud of all of the professionals in our global network who have worked so hard for this designation.”
The IDC Health Insights report is a biannual IT budget-tracking survey of several hundred life science companies. The survey, which polled 102 industry leaders on planned IT budgetary spending, technology priorities and vendor preference, asked participants to identify which vendors servicing the life science market they expect to spend money with on software, hardware and IT services over the next 12 months. IDC Health Insights: “Perspective: IDC Health Insights' Top Preferred Life Science Technology Vendors for 2013,” Document # HI239146, February 2013, Eric Newmark. About Accenture Accenture is a global management consulting, technology services and outsourcing company, with approximately 259,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012. Its home page is www.accenture.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts